Drug Discovery Opinion

The eukaryotic translation initiation factor eIF5A, which exists in two isoforms, was originally thought to be involved in formation of the first peptide bond during mRNA translation, but more recent work has implicated it as a translation elongation factor. In mammalian cells it has variously been associated with mediation of proliferation, apoptosis and inflammatory responses, although its mechanisms of action have remained vague. It has also been identified as a cofactor of the Rev trans-activator protein of HIV-1. eIF5A is unique in that it is the only known protein to contain the amino acid hypusine, formed posttranslationally via the sequential action of deoxyhypusine synthase (DHS) and deoxyhypusine hydroxylase (DOHH) acting at a specific lysine residue.

Based on the role of eIF5A in inflammation, a multi-institutional research team led by scientists at Indiana University School of Medicine has explored involvement of the protein in pancreatic islet dysfunction during the development of diabetes. In a low-dose streptozotocin mouse model of diabetes the team found that depletion of eIF5A (using siRNA) protected the mice from pancreatic β-cell loss and hyperglycemia. The depletion of eIF5A resulted in impaired translation of inducible nitric oxide synthase (iNOS)-encoding mRNA within islet cells. Further studies using an inhibitor of DHS, N¹-guanyl-1,7-diaminoheptane (GC7), demonstrated a requirement for hypusination in the action of eIF5A.

The study, published in the Journal of Clinical Investigation, demonstrates a role for eIF5A in inflammation-induced damage to islet cells. Since the negative effects of eIF5A depend on hypusination, DHS may represent a viable therapeutic target for diabetes. Further work will be necessary to establish the role of this pathway in development and progression of the human disease.

Related posts:

1. Non-peptide GLP-1 Agonist Shows Efficacy in Mouse Model of Diabetes Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease, diabetes and obesity. A...
2. Man or Mouse – It’s Important in Diabetes Research During the development of type 2 diabetes, uptake of glucose from the blood by muscle and fat cells in response...
3. Role for Death Protein in Stroke Ischaemic stroke is a leading cause of adult disability and death. Glutamate plays an essential role in neural development, excitatory...
4. New DPP-4 Inhibitor Demonstrates Glucose Control in Type 2 Diabetes Type-2 diabetes is a metabolic disorder that is increasing rapidly in the developed world. The disease is caused by reduced...
5. Allergy Drugs May Treat Obesity and Type 2 Diabetes Mast cells are best known for their role in allergic responses but a new study by researchers at Brigham and...

Related posts brought to you by Yet Another Related Posts Plugin.

 Email This Post

This entry was posted on Tuesday, May 25th, 2010 at 2:21 pm and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.